Association of Risk-Reducing Surgery in <emph type="ital">BRCA1</emph> or <emph type="ital">BRCA2</emph> Mutation Carriers With Cancer Risk and Mortality
JAMA2010Vol. 304(9), pp. 967–967
Citations Over TimeTop 1% of 2010 papers
Abstract
Among a cohort of women with BRCA1 and BRCA2 mutations, the use of risk-reducing mastectomy was associated with a lower risk of breast cancer; risk-reducing salpingo-oophorectomy was associated with a lower risk of ovarian cancer, first diagnosis of breast cancer, all-cause mortality, breast cancer-specific mortality, and ovarian cancer-specific mortality.
Related Papers
- → The Prognostic Value of Survivin Expression in Patients with Colorectal Carcinoma: A Meta-analysis(2013)27 cited
- → Survival impact of compliance in extra-perigastric lymphadenectomy for gastric cancer: 20 years of real-world data from a single institution(2022)7 cited
- → Glucosylsphingosine concentration is the most reliable response-parameter for low-dose ERT in homozygous N370S Gaucher patients(2018)
- → Clinical characteristics, genotype and outcome of Gaucher disease in Pakistani children(2019)
- → Job syndrome(2019)